Prospective study of C1 esterase inhibitor in the treatment of successive acute abdominal and facial hereditary angioedema attacks

Annals of Allergy, Asthma and Immunology

Volumn 106, Issue 1, 2011, Pages 62-68

  Wasserman, Richard L ^a   Levy, Robyn J ^b   Bewtra, Againdra K ^c   Hurewitz, David ^d   Craig, Timothy J ^e   Kiessling, Peter C ^f   Keinecke, Heinz Otto ^g   Bernstein, Jonathan A ^h  

^a DallasAllergyImmunology   (United States)

^b Family Allergy and Asthma Center   (United States)

^c CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Allergy Clinic of Tulsa   (United States)

^e PENN STATE COLLEGE OF MEDICINE   (United States)

^f CSL BEHRING GMBH   (Germany)

^g ACCOVION GMBH   (Germany)

^h UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR;

ABDOMINAL DISEASE; ABDOMINAL EDEMA; ABDOMINAL PAIN; ADOLESCENT; ADULT; ANGIONEUROTIC EDEMA; ARTICLE; CHILD; CONTROLLED STUDY; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FACE EDEMA; FEMALE; HEADACHE; HUMAN; INFLUENZA; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; SINGLE DRUG DOSE; UPPER RESPIRATORY TRACT INFECTION; VAGINA MYCOSIS;

ABDOMEN; ACUTE DISEASE; ADOLESCENT; ADULT; ANGIOEDEMAS, HEREDITARY; CHILD; COMPLEMENT C1 INHIBITOR PROTEIN; FACE; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 78650875213     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2010.10.012     Document Type: Article

References (30)

1. K. Bork Pasteurized C1 inhibitor concentrate in hereditary angioedema: pharmacology, safety, efficacy and future directions Expert Rev Clin Immunol 4 2008 13 20
2. A.E. Davis The pathophysiology of hereditary angioedema Clin Immunol 114 2005 3 9
3. A.M. Johnson, C.A. Alper, F.S. Rosen, and J.M. Craig C1 inhibitor: evidence for decreased hepatic synthesis in hereditary angioneurotic edema Science 173 1971 553 554
4. M. Cugno, A. Zanichelli, F. Foieni, S. Caccia, and M. Cicardi C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress Trends Mol Med 15 2009 69 78
5. A. Agostoni, and M. Cicardi Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients Medicine (Baltimore) 71 1992 206 215
6. T. Bowen, M. Cicardi, and K. Bork Hereditary angioedema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema Ann Allergy Asthma Immunol 100 suppl 2 2008 S30 S40
7. K. Bork, P. Staubach, and J. Hardt Treatment of skin swellings with C1-inhibitor concentrate in patients with hereditary angio-oedema Allergy 63 2008 751 757
8. A.T. Waytes, F.S. Rosen, and M.M. Frank Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate N Engl J Med 334 1996 1630 1634
9. M. Levi, G. Choi, C. Picavet, and C.E. Hack Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency J Allergy Clin Immunol 117 2006 904 908
10. A. Carugati, E. Pappalardo, L.C. Zingale, and M. Cicardi C1-inhibitor deficiency and angioedema Mol Immunol 38 2001 161 173
11. M. Cicardi, L.C. Zingale, A. Zanichelli, D.L. Deliliers, and S. Caccia The use of plasma-derived C1 inhibitor in the treatment of hereditary angioedema Expert Opin Pharmacother 8 2007 3173 3181
12. M. Juers, and A. Groener Virus safety of current plasma-derived C1-INH: the Aventis Behring experience J Allergy Clin Immunol 114 2004 S96 S98
13. A. Grner, T. Nowak, and W. Schfer An integrated approach to effective pathogen reduction for a plasma-derived C1 inhibitor concentrate Hmostaseologie 28 2008 A96
14. J. de Serres, A. Grner, and J. Lindner Safety and efficacy of pasteurized C1 inhibitor concentrate (Berinert P) in hereditary angioedema: a review Transfus Apher Sci 29 2003 247 254
15. T.J. Craig, R.J. Levy, and R.L. Wasserman Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks J Allergy Clin Immunol 124 2009 801 808
16. K. Bork, G. Meng, P. Staubach, and J. Hardt Treatment with C1 inhibitor concentrate in abdominal pain attacks of patients with hereditary angioedema Transfusion 45 2005 1774 1784
17. L. Varga, G. Szplaki, and B. Visy C1-inhibitor (C1-INH) autoantibodies in hereditary angioedema: strong correlation with the severity of disease in C1-INH concentrate nave patients Mol Immunol 44 2007 1454 1460
18. Farkas H, Varga L, Csuka L, et al. The presence and frequency of IgM type antibodies to C1-inhibitor (C1-INH) are not related to the administration of C1-INH concentrate in patients with hereditary angioedema (HAE). Paper presented at: 29th Congress of the European Academy of Allergy and Clinical Immunology; June 5-9, 2010; London, England. Poster abstract 1178-P.
19. K. Bork, P. Staubach, A.J. Eckhardt, and J. Hardt Symptoms, course, and complications of abdominal attacks in hereditary angioedema due to C1 inhibitor deficiency Am J Gastroenterol 101 2006 619 627
20. B.L. Zuraw Clinical practice: hereditary angioedema N Engl J Med 359 2008 1027 1036
21. M. Kunschak, W. Engl, and F. Maritsch A randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedema Transfusion 38 1998 540 549
22. H. Farkas, L. Jakab, and G. Temesszentandrsi Hereditary angioedema: a decade of human C1-inhibitor concentrate therapy J Allergy Clin Immunol 120 2007 941 947
23. B.L. Zuraw, P.J. Busse, and M. White Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema N Engl J Med 363 2010 513 522
24. K. Bork, G. Meng, P. Staubach, and J. Hardt Hereditary angioedema: new findings concerning symptoms, affected organs, and course Am J Med 119 2006 267 274
25. D.A. Wilson, A.J. Castaldo, M.K. Vernon, A.M. Rentz, and M.B. Blaustein Effect of hereditary angioedema: health-related quality of life, depression, productivity, and social consequences J Allergy Clin Immunol 123 2009 S142
26. D.A. Wilson, K. Bork, E.P. Shea, A.M. Rentz, M.B. Blaustein, and W.E. Pullman Economic costs associated with acute attacks and long-term management of hereditary angioedema Ann Allergy Asthma Immunol 104 2010 314 320
27. K. Bork, J. Hardt, K.H. Schicketanz, and N. Ressel Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency Arch Intern Med 163 2003 1229 1235
28. M. Cicardi, A. Banerji, and F. Bracho Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema N Engl J Med 363 2010 532 541
29. M. Cicardi, R.J. Levy, and D.L. McNeil Ecallantide for the treatment of acute attacks in hereditary angioedema N Engl J Med 363 2010 523 531
30. H.J. Longhurst Emergency treatment of acute attacks in hereditary angioedema due to C1 inhibitor deficiency: what is the evidence? Int J Clin Pract 59 2005 594 599